Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
University Hospital, Toulouse
Chinese University of Hong Kong
Stanford University
Peking University People's Hospital
CHU de Reims
Mashhad University of Medical Sciences
Centre Francois Baclesse
Sohag University
Providence Health & Services
M.D. Anderson Cancer Center
Washington University School of Medicine
Baptist Health South Florida
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
Sun Yat-sen University
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Jinling Hospital, China
Baptist Health South Florida
Providence Health & Services
Vall d'Hebron Institute of Oncology
Imperial College London
Columbia University
Changsha Medical University
Federation Francophone de Cancerologie Digestive
Institute of Liver and Biliary Sciences, India
Hoosier Cancer Research Network
Kaohsiung Medical University
China Medical University, China
Federation of Italian Cooperative Oncology Groups
Second Affiliated Hospital of Soochow University
Washington University School of Medicine
University of Kentucky
University of Kentucky
Trans Tasman Radiation Oncology Group
Qilu Hospital of Shandong University
University of Florida
Assiut University
Tata Medical Center
Tata Memorial Centre
Second Affiliated Hospital of Soochow University
Peking University
Assistance Publique - Hôpitaux de Paris
Consorzio Oncotech
MercyOne Des Moines Medical Center
Stanford University
Mary Crowley Medical Research Center
Centre Georges Francois Leclerc
Stanford University